Selskabets formål er at eje kapitalandele samt al virksomhed, som efter bestyrelsens skøn har forbindelse hermed.
| Year | Revenue | Profit/Loss | Total Assets | Equity | Employees | Report |
|---|---|---|---|---|---|---|
| 2025 | 9.2 mio. | -83.2 mio. | 1.2 mia. | 1.2 mia. | 511 | |
CVR: 37397776
Secondary names: SSI Diagnostica Group Holding A/S
Previous names: KR 603 A/S, Adelis DK Holding 3 A/S
Compared to 50.000 companies in Ikke-finansielle holdingselskaber
Comparison is based on industry median values
Joseph Edward Bernardo joined the board
Stig Løkke Pedersen left the board
Egil Mølsted Madsen left the board
The financial health of SSI Diagnostica Holding A/S has deteriorated significantly over recent years, with a notable decline in profitability. Revenue increased from 2,068,500 DKK in 2022 to 9,161,134 DKK in 2025, yet the company reported substantial losses, with profits plummeting to -83,197,189 DKK in 2025. Despite these losses, equity remains strong at 1,228,136,566 DKK, indicating a solid capital base. The company's position within the non-financial holding sector appears precarious due to its declining profit margins and increasing operational challenges.
AI-generated summary
Companies in the same industry and area
companydata.dk